About the CAR-T Access Coalition and Its Playbook

The CAR-T Access Coalition is a collaboration convened by the Alliance for Regenerative Medicine to help community oncology practices and hospitals deliver CAR-T close to where patients live. Most people with cancer are cared for in community settings, but most CAR-T is not delivered there. The coalition brings together clinicians, program administrators and organizations that have already done this work, and publishes what they learned as a practical playbook.

Our Collaborating Partners

No single organization can close the CAR-T access gap. These partners contribute experience, operational tools, standards expertise and the patient perspective to the playbook.

Bristol Myers Squibb

Kite a Gilead Company

Legend Biotech

InspiroGene by McKesson

Powered by the Alliance for Regenerative Medicine

ARM is the global advocacy organization for the cell and gene therapy sector, representing more than 400 members. This coalition is one of ARM's access programs, aimed where most patients already receive their cancer care.

Statistics: Simmons, Cross & Pittos, Front Oncol 2026;16:1712533

Visit ARM

More than 400+ ARM members in 25 countries

Just 25% of eligible patients receive CAR-T

Under 15% of CAR-T given outside academic centers

Ready to Explore the Playbook

Eight domains, each one a decision your program has to make. Start with the one in front of you.

Start the Playbook